Clin2
NCT06139224Possibly a fitRecruiting

Gut Bacteria and Inflammation in HIV and Heavy Drinking

Alcohol Use DisorderHuman Immunodeficiency Virus

Part of Immune system & allergy, Infections, Mental health clinical trials.

This study looks at how gut bacteria and inflammation interact in people with both HIV and heavy alcohol use. It aims to find new ways to improve health by understanding these connections.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
45 years to 75 years
Study type
Interventional

Who can take part

  • You are 21 to 75 years old and have HIV.
  • Your HIV is well-controlled on the same medications for at least 6 months, and you have never taken AZT or D4T.
  • You drink heavily (men: 4+ drinks often, women: 3+ drinks often).
  • Your BMI is between 25 and 40.
  • You are not taking antibiotics, probiotics, or certain supplements (like high-fiber or anti-inflammatory supplements) within the last 4 weeks, or you can stop them for 2 weeks before starting.
  • You are not taking GLP-1 weight-loss drugs (like Ozempic) within the last 4 weeks, or you can stop them for 4 weeks.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06130137Not yet recruiting
Gut microbiome study for HIV and hepatitis B

This study looks at the bacteria in the gut of people with HIV or hepatitis B. You may be asked to provide a stool sample to help researchers understand how these infections affect your microbiome.

NCT06771843Recruiting
Helping men with HIV reduce drinking and improve HIV prevention

This study tests whether helping men with HIV who also drink heavily can lower their alcohol use and improve how well HIV treatment works to prevent passing the virus to others. It's for men living in fishing communities in Uganda.

Kampala
NCT05163301Recruiting
Alcohol relapse prevention for adults living with HIV

This study looks at ways to help people with HIV reduce the chance of heavy drinking coming back after a period of lower-risk drinking. It will use regular patient-reported check-ins about alcohol use to understand relapse patterns and test the approach’s impact.

Baltimore, Maryland
NCT05288790Recruiting· Phase 2
Study how gut chemicals and alcohol affect heart risk in HIV

This Phase 2 study looks at how “microbiome metabolites” (chemicals from gut bacteria) and alcohol may affect heart and blood vessel risk in people living with HIV. If you qualify, you may be asked to follow a study plan to see how these factors change health markers related to cardiovascular disease.

Nashville, Tennessee
NCT07462767Not yet recruiting· Phase 1/Phase 2
Microbiome therapy to reduce alcohol harm in people with HIV

This trial tests whether a special microbiome treatment can help reduce alcohol-related harm in people with HIV. You may be eligible if you have HIV and have been drinking alcohol recently.

New Orleans, Louisiana
NCT06513819Recruiting· Phase 1
HIV and Alcohol Study for People on Multiple Medications

This study looks at how alcohol use affects people with HIV who take multiple medications, including certain brain or nerve drugs. It aims to find safer ways to manage their health.

West Haven, Connecticut

Hear when a new Alcohol Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.